National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1156227

History of Changes from the VAERS Wayback Machine

First Appeared on 4/23/2021

VAERS ID: 1156227
VAERS Form:2
Age:26.0
Sex:Female
Location:Massachusetts
Vaccinated:2021-03-19
Onset:2021-03-22
Submitted:0000-00-00
Entered:2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 1 - / SYR

Administered by: Public      Purchased by: ??
Symptoms: CSF protein increased, Facial paralysis, Hypoaesthesia, Lumbar puncture abnormal, Muscular weakness, Hypoaesthesia oral, Immunoglobulin therapy, Magnetic resonance imaging spinal, Magnetic resonance imaging head

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Sertraline (Zoloft) 200mg Norethindrone-Estradiol-Iron (1.5/30, 28, oral)
Current Illness: Patient reported slight post-nasal drift and the "sniffles" 2 weeks prior to receiving the vaccine that only lasted a few days.
Preexisting Conditions: Anxiety, Migraines
Allergies: None
Diagnostic Lab Data: A lumbar puncture (to collect CSF) and brain MRI and total spine were done.
CDC 'Split Type':

Write-up: 3 days after receiving the Pfizer COVID-19 vaccination, the patient reported numbness in her bilateral toes that progressed to numbness and weakness of her bilateral legs. 5 days after the onset of her initial symptoms, the patient noted bilateral numbness in her fingers and her mouth, that also progressed to weakness in her bilateral arms. A few days later, the patient noticed a right-sided facial droop that brought her to the ED. Given the patient''s symptoms and elevated protein in the patient''s CSF (obtained via lumbar puncture), the patient''s symptoms are concerning for Guillain-Barre syndrome. The patient was started today on 5 days of immune globulin (PRIVIGEN) 10 % IV infusion 25 g.


Changed on 5/7/2021

VAERS ID: 1156227 Before After
VAERS Form:2
Age:26.0
Sex:Female
Location:Massachusetts
Vaccinated:2021-03-19
Onset:2021-03-22
Submitted:0000-00-00
Entered:2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 1 - / SYR

Administered by: Public      Purchased by: ??
Symptoms: CSF protein increased, Facial paralysis, Hypoaesthesia, Lumbar puncture abnormal, Muscular weakness, Hypoaesthesia oral, Immunoglobulin therapy, Magnetic resonance imaging spinal, Magnetic resonance imaging head

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Sertraline (Zoloft) 200mg Norethindrone-Estradiol-Iron (1.5/30, 28, oral)
Current Illness: Patient reported slight post-nasal drift and the "sniffles" 2 weeks prior to receiving the vaccine that only lasted a few days.
Preexisting Conditions: Anxiety, Migraines
Allergies: None None
Diagnostic Lab Data: A lumbar puncture (to collect CSF) and brain MRI and total spine were done.
CDC 'Split Type':

Write-up: 3 days after receiving the Pfizer COVID-19 vaccination, the patient reported numbness in her bilateral toes that progressed to numbness and weakness of her bilateral legs. 5 days after the onset of her initial symptoms, the patient noted bilateral numbness in her fingers and her mouth, that also progressed to weakness in her bilateral arms. A few days later, the patient noticed a right-sided facial droop that brought her to the ED. Given the patient''s symptoms and elevated protein in the patient''s CSF (obtained via lumbar puncture), the patient''s symptoms are concerning for Guillain-Barre syndrome. The patient was started today on 5 days of immune globulin (PRIVIGEN) 10 % IV infusion 25 g.


Changed on 5/14/2021

VAERS ID: 1156227 Before After
VAERS Form:2
Age:26.0
Sex:Female
Location:Massachusetts
Vaccinated:2021-03-19
Onset:2021-03-22
Submitted:0000-00-00
Entered:2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 1 - / SYR

Administered by: Public      Purchased by: ??
Symptoms: CSF protein increased, Facial paralysis, Hypoaesthesia, Lumbar puncture abnormal, Muscular weakness, Hypoaesthesia oral, Immunoglobulin therapy, Magnetic resonance imaging spinal, Magnetic resonance imaging head

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Sertraline (Zoloft) 200mg Norethindrone-Estradiol-Iron (1.5/30, 28, oral)
Current Illness: Patient reported slight post-nasal drift and the "sniffles" 2 weeks prior to receiving the vaccine that only lasted a few days.
Preexisting Conditions: Anxiety, Migraines
Allergies: None None
Diagnostic Lab Data: A lumbar puncture (to collect CSF) and brain MRI and total spine were done.
CDC 'Split Type':

Write-up: 3 days after receiving the Pfizer COVID-19 vaccination, the patient reported numbness in her bilateral toes that progressed to numbness and weakness of her bilateral legs. 5 days after the onset of her initial symptoms, the patient noted bilateral numbness in her fingers and her mouth, that also progressed to weakness in her bilateral arms. A few days later, the patient noticed a right-sided facial droop that brought her to the ED. Given the patient''s symptoms and elevated protein in the patient''s CSF (obtained via lumbar puncture), the patient''s symptoms are concerning for Guillain-Barre syndrome. The patient was started today on 5 days of immune globulin (PRIVIGEN) 10 % IV infusion 25 g.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1156227&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166